Allergy and angiitis: two aspects of Churg-Strauss syndrome.
Morishita
M
M
D018927:Anti-Asthmatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001249:Asthma / Q000150:complications / Q000188:drug therapy; D001706:Biopsy; D015267:Churg-Strauss Syndrome / Q000175:diagnosis / Q000209:etiology / Q000276:immunology / Q000473:pathology*; D006099:Granuloma / Q000473:pathology; D006801:Humans; D007211:Indoles; D020024:Leukotriene Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D008565:Membrane Proteins; D048448:Phenylcarbamates; D010994:Pleura / Q000473:pathology; D018077:Receptors, Leukotriene; D013449:Sulfonamides; D014105:Tosyl Compounds / Q000009:adverse effects / Q000627:therapeutic use
D018927:Anti-Asthmatic Agents; D007211:Indoles; D020024:Leukotriene Antagonists; D008565:Membrane Proteins; D048448:Phenylcarbamates; D018077:Receptors, Leukotriene; D013449:Sulfonamides; D014105:Tosyl Compounds; C412375:cysteinyl leukotriene receptor 2; C083169:leukotriene D4 receptor; C062735:zafirlukast